Duchenne Muscular Dystrophy Market

May 04, 2020

10 likes | 46 Views

The market size of Duchenne Muscular Dystrophy in the 7 MM was found to be USD 266.06 Million in 2017. The United States accounts for the largest Duchenne Muscular Dystrophy (DMD) market size in comparison to EU5 and Japan. The total diagnosed DMD prevalent population in 2017 was 27,685 (in 7MM). The key players in Duchenne Muscular Dystrophy Markt include Sarepta Therapeutics, Santhera Pharmaceuticals, Italfarmaco, Catabasis Pharmaceuticals, NS Pharma, Pfizer, Taiho Pharmaceutical, FibroGen, Daiichi Sankyo, Hoffmann-La Roche, Nobelpharma, Cumberland Pharma, and many others. For more details visit: https://www.delveinsight.com/report-store/duchenne-muscular-dystrophy-market#infographics #Duchenne Muscular Dystrophy #Duchenne Muscular Dystrophy Market #Duchenne Muscular Dystrophy Epidemiology #Duchenne Muscular Dystrophy key companies #Duchenne Muscular Dystrophy market size #DMD

Share Presentation

Embed Code

Link

DelveInsight

Download Presentation

Duchenne Muscular Dystrophy Market

An Image/Link below is provided (as is) to download presentation Download Policy: Content on the Website is provided to you AS IS for your information and personal use and may not be sold / licensed / shared on other websites without getting consent from its author. Content is provided to you AS IS for your information and personal use only. Download presentation by click this link. While downloading, if for some reason you are not able to download a presentation, the publisher may have deleted the file from their server. During download, if you can't get a presentation, the file might be deleted by the publisher.

E N D

Presentation Transcript

Duchenne Muscular Dystrophy

Duchenne Muscular Dystrophy. Curtis Kendall December 5, 2006. Duchenne Muscular Dystrophy Facts. DMD affects mostly males at a rate of 1 in 3,500 births. There are over 200 types of mutations that can cause any one of the forms of muscular dystrophy.

1.4k views • 12 slides

Duchenne Muscular Dystrophy

Duchenne Muscular Dystrophy. PG SBI3U. Introduction. Duchenne Muscular Dystrophy (DMD) is the most common and most serious form of muscular dystrophy 1 in 3500 boys are affected DMD is a fatal genetic disorder that damages muscle tissue

2.12k views • 14 slides

Duchenne Muscular Dystrophy

NotesMuscular Dystrophy (MD) names a group of 9 different variations of a disease that is characterized by the deterioration of muscle fibers. Duchenne MD (DMD) is the form that affects mainly children, ages 2 to 6. It is found on the X-chromosome and is therefore more prominent in boys. . Sympto

293 views • 6 slides

Duchenne s Muscular Dystrophy

Background. Most common muscular dystrophyAffects 1 in 4000 male infantsInherited X-linked recessiveApprox 1/3 cases are new mutationDeletion of chromosome material on short arm of X chromosomeThis area codes for dystrophin which maintains integrity of muscle cell wall.Proximal muscle weakness

374 views • 12 slides

Duchenne Muscular Dystrophy

Duchenne Muscular Dystrophy. Sherri Garcia Muscular Dystrophy: Walk a Mile in Their Shoes CDC’s 2005 Science Ambassador Program. Overview. Sympathy vs. empathy Basic information about Duchenne muscular dystrophy Inheritance Prevalence Symptoms Treatments. Sympathy

1.01k views • 18 slides

Duchenne Muscular Dystrophy Becker Muscular Dystrophy

476 views • 3 slides

Duchenne Muscular Dystrophy

Duchenne Muscular Dystrophy. Presented by: Sujitha B Subramaniam 11408044 IV yr Genetic Engineering SRM University. DUCHENNE MUSCULAR DYSTROPHY ( DMD ) is a recessive X-linked form of muscular dystrophy, which results in muscle degeneration, difficulty in walking , breathing, and death.

946 views • 21 slides

Duchenne Muscular Dystrophy

Duchenne Muscular Dystrophy. Erin Kim. What is Duchenne Muscular Dystrophy?. Duchenne Muscular Dystrophy (DMD) is a type of muscular dystrophy is a recessive genetic disorder causing the fast deterioration of muscles. Symptoms.

1.49k views • 10 slides

Duchenne Muscular Dystrophy

Irene Cofie Jade Jackson 11/16/11. Duchenne Muscular Dystrophy. History of Duchenne Muscular Dystrophy (DMD). Guillaume Benjamin Amand Duchenne was a French Neurologist, who was the first to describe DMD, during the 1860s. A Sex Linked Disorder.

838 views • 11 slides

Duchenne Muscular Dystrophy (DMD)

Duchenne Muscular Dystrophy (DMD). By: Jon Jensen. What We Will Be Discussing Today. Topic 1. Topic 2. Phenotype Description and Inheritance. Normal Gene Function. The 6 Main topics in relation to DMD:. An Introduction to this Disorder. Diagnosis and Treatment. Implications. Topic 3.

1.88k views • 23 slides

Duchenne Muscular dystrophy

Duchenne Muscular dystrophy. By: Logan Gillings , Reyes E . Cause Of Disease. Is a genetic disorder that causes progressive muscle weakness as individual muscle cells die. An absence of dystrophin , a protein that helps keep muscle cells intact. Can be inherited . Mutation Type.

344 views • 10 slides

Duchenne Muscular Dystrophy

Duchenne Muscular Dystrophy . (DMD). History of DMD. It was first described by a french neurologist named Guillaume Benjamin Amand Duchenne in 1868.

373 views • 9 slides

Duchenne Muscular Dystrophy

A.K.A. Pseudohypertrophic Muscular Dystrophy. Duchenne Muscular Dystrophy. By Mason Bross. A.K.A. Duchenne and Becker muscular dystrophy. Inheritance. DMD is a sex-linked disorder that most commonly appears in young boys.

673 views • 7 slides

Duchenne Muscular Dystrophy

Duchenne Muscular Dystrophy. By Steven Shikhel . Guillaume-Benjamin-Amand Duchenne. Duchenne Muscular Dystrophy (DMD). Guillaume-Benjamin- Amand Duchenne credited with discovery dystrophy voluntary muscles progressively weaken Effect starts and is worse at extremities, mostly legs

1.02k views • 52 slides

Duchenne Muscular Dystrophy: Neuromuscular Management

Duchenne Muscular Dystrophy: Neuromuscular Management. Introduction. Muscles weaken due to lack of dystrophin Regular checkups with specialists are required Steroids are the only drugs which alter the natural history of DMD Should only be prescribed by doctors with appropriate expertise

612 views • 35 slides

Duchenne Muscular Dystrophy

Duchenne Muscular Dystrophy. A PHM142 Presentation. PHM142 Fall 2012 Instructor: Dr. Jeffrey Henderson. Matthew Deiana Michael De Marco Gheorghe Mando. Intro, Pathogenesis, and Symptoms. What is DMD?. A recessive X-linked form of muscular dystrophy

1.04k views • 16 slides

Duchenne muscular dystrophy (DMD)

Duchenne muscular dystrophy (DMD). Philip Ord Isaac Lalich. A patient with Duchenne muscular dystrophy. Introduction. Characteristics Weakness Swollen Calve Muscles Strange Gait Muscle Wasting Loss of Ambulation Respiratory Insufficiency Scoliosis Cardiomyopathy (Some Cases ).

422 views • 11 slides

Duchenne muscular dystrophy (DMD)

Duchenne muscular dystrophy (DMD). Arnd ís Auður Sigmarsdóttir. DMD. Versnandi myopathia sem leiðir til vöðvar ýrnunar og veikleika X - tengd víkjandi stökkbreyting í DMD geni Vöntun á dystrophin prótíni 1:3500 lifandi fæddum drengjum Til í stúlkum Turner 46XY st úlkur

434 views • 17 slides

Duchenne Muscular Dystrophy

Duchenne Muscular Dystrophy. BRIAN CHANDA CHILUBA Dip.PT; Cert. NDT NEUROLOGY CLASS PRESENTATION. Overview. Basic information about Duchenne muscular dystrophy Inheritance Prevalence Symptoms Treatments. What Is Duchenne Muscular Dystrophy? (1). Genetic Progressive muscle weakness

880 views • 23 slides

Duchenne Muscular Dystrophy

Duchenne Muscular Dystrophy. By: miki kennerly & jacob Heisel Period 3. History. Guillaume-Benjamin- Amand - Duchenne discovered muscular dystrophy in the 1860’s in France. He built a “portable electrical device” used to view muscles in response to health and disease.

569 views • 8 slides

Duchenne Muscular Dystrophy

Duchenne Muscular Dystrophy. By: Andrea Ortega. Chromosome Graphic. Genetic Disorder. Is a muscle disease that weakens the muscles in the human body. Symptoms & Effects. Weakness to muscles, Lose ability to walk by the age of 12. Frequent falls. Deformities. Diagnosis.

345 views • 9 slides

Duchenne Muscular Dystrophy and Becker Muscular Dystrophy Market Analysis to 2020

The Duchenne Muscular Dystrophy (DMD) and Becker Muscular Dystrophy (BMD) pipeline consists of 84 molecules across all stages of development. The analysis revealed a high degree of innovation and diversity in this indication, with 70% of the pipeline being first-in-class products, acting on 13 first-in-class targets.

361 views • 5 slides

More Related